Form 4: Perrigo EVP Robert Willis Receives RSU Grant

Perrigo Company plc EVP and CHRO Robert Willis was granted 22,388 restricted stock units vesting over three years.

Summary

• Robert Willis, Executive Vice President and Chief Human Resources Officer at Perrigo Company plc, received a grant of 22,388 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one ordinary share of Perrigo Company plc.
• The RSUs are scheduled to vest in three equal annual installments, beginning on May 13, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation that carries no significant signal regarding company performance or outlook.

Positives

• The grant aligns the interests of the executive with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• The value of the granted equity is subject to market fluctuations in Perrigo's share price.

Future Outlook

The RSUs vest in three equal annual installments starting May 13, 2027, contingent upon continued service.

Industry Context

StockSavvy.ai notes that equity grants to key executives are standard corporate governance practices intended to incentivize long-term retention and performance alignment within the pharmaceutical and consumer health sectors.

Comparison to Industry Standards

• The use of multi-year vesting schedules for RSUs is consistent with standard executive compensation practices among large-cap pharmaceutical and consumer goods companies.
• The grant size is commensurate with the role of an EVP and CHRO at a company of Perrigo's market capitalization.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation grant.

Next Steps

• Vesting of the first tranche of RSUs on May 13, 2027.

Key Dates

Keywords

Perrigo, PRGO, Form 4, Insider Transaction, Restricted Stock Units, Executive Compensation